GlassScriptPhysician profile
Laura Jennifer Libby
NPI 1568607703
$11,709.16
in general payments reported to CMS, 2019-2025
32 companies · $2,357 in 2025
The $2,357 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,542 · 2020: $948 · 2021: $1,340 · 2022: $1,387 · 2023: $1,905 · 2024: $2,230 · 2025: $2,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,432 · Education: $58.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,432.30 |
| Education | $58.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,138.95 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,028.71 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,492.69 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Insmed, INC. | $913.05 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $855.98 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $761.97 | 2019-2025 | Dupixent |
| Baxter Healthcare | $449.79 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Electromed, INC. | $427.91 | 2019-2025 | Smartvest |
| Advanced Respiratory, INC | $296.90 | 2019-2021 | |
| Philips North America LLC | $288.37 | 2020-2025 | Vest Therapy Und, (8874) Incourage |
| Actelion Pharmaceuticals US, INC. | $249.61 | 2019-2024 | Opsumit, Uptravi |
| Takeda Pharmaceuticals U.S.A., INC. | $217.48 | 2020-2025 | Glassia, Aralast |
| Grifols USA, LLC | $194.08 | 2022-2024 | Prolastin-C Liquid |
| Verona Pharma, INC. | $161.22 | 2025 | Ohtuvayre |
| Amgen INC. | $154.10 | 2022-2024 | Tezspire |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $148.56 | 2021-2024 | Nuzyra |
| Pulmonx Corporation | $141.04 | 2023 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Vifor Pharma, INC. | $106.18 | 2025 | Zemaira |
| Mylan Specialty L.P. | $96.17 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $87.69 | 2019-2024 | Keytruda |
| Novartis Pharmaceuticals Corporation | $85.90 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $66.71 | 2020-2025 | Acthar |
| Lilly USA, LLC | $57.59 | 2024 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $54.73 | 2019 | |
| Circassia INC. | $38.53 | 2019 | |
| Shionogi INC | $38.22 | 2021 | |
| Genentech USA, INC. | $37.55 | 2019 | |
| Shire North American Group INC | $36.75 | 2019 | |
| Pfizer INC. | $30.08 | 2019-2022 | |
| United Therapeutics Corporation | $23.91 | 2024 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $16.49 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Libby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.